Professional Documents
Culture Documents
Nubain Mechanism of Action
Nubain Mechanism of Action
Narcotic agonist-analgesic of kappa opiate receptors and partial antagonist of mu opiate receptors; inhibits ascending pain pathways, thus altering response to pain; produces analgesia, respiratory depression, and sedation
Absorption
Onset: IM, 15 min; IV, 2-3 min Duration: 3-6 hr Peak plasma time: IM, 30 min; IV, 1-3 min
Distribution
Protein bound: Not significant
Metabolism
Metabolized in liver
Elimination
Half-life: 5 hr Excretion: Urine, feces
Pain Non-opioid-tolerant patients: 10-20 mg/70kg IV/IM/SC q3-6hr PRN; individual dose not to exceed 20 mg Opioid-dependent patients: Administer dose, and observe for withdrawal signs
Not to exceed 160 mg/day
Anesthesia Supplement 0.3-3 mg/kg IV over 10-15 minutes, then 0.25-0.5 mg/kg PRN Opioid-Induced Pruritus (Off-label) Prevention and treatment Dosing Modifications Renal impairment: Caution; dose reduction may be necessary; monitor
Hepatic impairment: Caution; dose reduction may be necessary; monitor